Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yishen Huazhuo granules in membranous nephropathy
CTR20170801Phase 2Terminated
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Sep 2017
- Countries
- 1
01
Overview
A Phase 2 trial of Yishen Huazhuo Granules in membranous glomerulonephritis (MGN), sponsored by Tianjin Institute of Pharmaceutical Research. Started Sep 2017; status: terminated.
02
Drugs
Yishen Huazhuo Granules
03
Conditions
membranous glomerulonephritis (MGN)
Beyond the preview
Go deeper on CTR20170801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170801.